The Concomitant Use of Melatonin and Molnupiravir in the Treatment of COVID-19: Mini Review
Bangladesh Journal of Medical Science
; 22(1):32-37, 2023.
Article
in English
| EMBASE | ID: covidwho-2198592
ABSTRACT
With the ongoing pandemic declared by the World Health Organization,the number of hospitalizations and deaths caused by COVID-19 is increasing dramatically. As new variants of SARS-CoV-2 emerge, new combination therapies are needed to reduce the risk of COVID-19spreadduring this time of increased transmission risk. In this case, it is vitalto strengthen the immune system against highly inflammatory conditions such as the cytokine storm caused by COVID-19. This brief review highlights the benefits of taking melatonin and the new antiviral drug molnupiravir together in the treatment of COVID-19. Webelieve that this combination therapy against COVID-19 would be of great benefit and should be considered as an adjuvant therapy in the treatment of this disease. Copyright © 2023, Ibn Sina Trust. All rights reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Bangladesh Journal of Medical Science
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS